Specialties & Topics
- Arthritis/Rheumatic Disease
- Breast Cancer
- GERD/Peptic Ulcers
An ongoing dialogue on HIV/AIDS, infectious diseases,
September 18th, 2009
Integrase Inhibitors: In Search of an Abbreviation
The alphabet soup that characterizes HIV therapeutics has always been one of its quirky challenges — for example, who could possibly know that 3TC, CBV, TZV, EPZ, and LAM all refer to drugs that are (or contain) lamivudine?
This drives our ID fellows nuts, and is certainly a strong deterrent to non-HIV specialists to learning the field.
(Maybe that’s why they pay us the big bucks… oh wait.)
And while we’ve grown comfortable with the abbreviations for the 3 oldest drug classes — NRTI, NNRTI, and PI — what are we to do with integrase inhibitors? Some candidates:
- “II” — sounds funny when you say it (“eye-eye”), and could be confused with “eleven” depending on the font
- “INSTI” — for “integrase strand transfer inhibitor”; I’ve already seen this one around a lot, but have also seen it written “InSTI” (lower-case n), which is hard to type
- “INI” — for “INtegrase Inhibitor”; same upper vs lower-case issue as “INSTI”, and saying “INI” always has an anatomic (especially umbilical) connotation to it
Still not sure where we’ll end up with this one, but I suspect “INSTI” will rule the day.
Comments are closed.
Paul E. Sax, MD
Learn more about HIV and ID Observations.
- Should Doctors Still Be Allowed to Wear White Coats? You Decide (43)
- Are ID Doctors the Worst Dressed Specialists? (39)
- Which Infectious Diseases Do We Fear Too Much? Which Not Enough? (33)
- Are Fluoroquinolones Really More Dangerous Than Other Antibiotics? (30)
- How to Make the Flu Vaccine More Popular, Warts and All (24)
- A Riddle, the 2015 Clinical Trial of the Year, and a Guaranteed Laugh for All ID Doctors
- Medical Marijuana and Painful Neuropathy — An Opportunity to Make Us Believers
- Here’s an Idea: Justify Your Specialty’s (Low) Relative Salary Using Moral Superiority
- Elbasvir/Grazoprevir Combination Pill for HCV a Welcome New Option — With a Few Buts
- IV and Injectable HIV Treatments Are Much Discussed — But Won’t Be Here Anytime Soon
Subscribe to HIV and ID Observations via Email
- Frozen Feces Are Effective for Recurrent C. Difficile Infection
- Daclatasvir-Based HCV Therapy in Patients with Advanced Cirrhosis or Post-Transplant HCV Recurrence
- Does HIV Replication Persist in Patients on Antiretroviral Therapy?
- Factors Associated with Successful Discontinuation of Oral Antivirals in Chronic HBV
- Zika Virus Spreads Quickly in Parts of the Americas
Physician's First WatchToday's breaking medical news
- Abacavir AIDS aids clinical care antibiotics antiretroviral therapy ART atazanavir baseball CDC C diff CROI cure darunavir dolutegravir efavirenz elvitegravir etravirine FDA HCV hepatitis C HIV HIV testing ID Learning Unit Infectious Diseases influenza lamivudine Link-o-Rama lyme disease Massachusetts MRSA Patient Care PEP Policy PrEP prevention primary care raltegravir Research resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir vaccination